Request quotation

    Share
    Find: 15:03 03/08/2026

    Bid info

    Project name/purchase estimate
    Procurement of vaccination services for 12 months of use
    Bid name
    Procurement of vaccination services for 12 months of use

    Basic information of the request for quotation

    Request for quotation code
    RQ2600031231-00
    Status
    Posted
    Name of request for quotation
    Request quotation
    Unit requesting quote
    Kiên Giang General Hospital
    Address of the unit requesting a quote
    Province Kiên Giang
    Address of the unit requesting a quote (After merge)
    13 Nam Ky Khoi Nghia, Phường Rạch Giá, Province An Giang
    Categorize quotation requests
    Bidding package for purchasing medicine

    Contact information of the person responsible for receiving the quotation

    Full Name
    Ngô Vị Đại
    Position
    Staff
    Phone number
    0919.663336
    Address
    No. 13 Nam Ky Khoi Nghia Street, Rach Gia Ward, An Giang Province
    Email
    [email protected]

    How to receive quotation

    Form of receiving quotation
    Offline
    Location of request for quotation
    http://muasamcong.mpi.gov.vn
    Quotation acceptance time
    Since 03/08/2026 15:03 To date 13/08/2026 17:00
    Validity period of quotation
    12 Month kể từ ngày 13/08/2026 17:00
    Request for quotation
     

    Content of request for quotation

    Filter data

    data/page
    No Medicine code Active ingredient name Technical criteria group Concentration or content How to use Dosage form Unit Quantity Feature
    1
    Meningococcal type A, C, Y, W vaccine
    After reconstitutioning, each dose (0.5ml) contains polysaccharide neisseria meningitidis group A (plus the protein to detoxify tetanus (carrier)) 5mcg PSA ~ 15mcg TT; Polysaccharide Neisseria Meningitidis Group C (plus the protein to detoxify tetanus (substance)) 5mcg PSC ~ 15mcg TT; Polysaccharide Neisseria Meningitidis group W-135 (plus with a protein to detoxify tetanus (carrier)) 5mcg PSW ~ 7.5mcg TT; Polysaccharide Neisseria Meningitidis Group Y (plus with tetanus detoxification protein (carrier) 5mcg psy ~ 6.5mcg TT
    Group 1
    After reconstitutioning, each dose (0.5ml) contains polysaccharide neisseria meningitidis group A (plus the protein to detoxify tetanus (carrier)) 5mcg PSA ~ 15mcg TT; Polysaccharide Neisseria Meningitidis Group C (plus the protein to detoxify tetanus (substance)) 5mcg PSC ~ 15mcg TT; Polysaccharide Neisseria Meningitidis group W-135 (plus with a protein to detoxify tetanus (carrier)) 5mcg PSW ~ 7.5mcg TT; Polysaccharide Neisseria Meningitidis Group Y (plus with tetanus detoxification protein (carrier) 5mcg psy ~ 6.5mcg TT
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    2
    Meningococcal type B vaccine
    Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg
    Group 1
    Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    600
    3
    Pneumococcal 15-strain vaccine
    Each dose (0.5 ml) contains 2 mcg of pneumococcal polysaccharides of serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F and 4 mcg of serotype 6B, conjugated to the carrier protein CRM197, and adsorbed onto the substrate. aluminum phosphate salt supplement
    Group 1
    0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    800
    4
    20-strain pneumococcal vaccine
    Pneumococcal polysaccharide type 1 serum 2.2mcg; Pneumococcal polysaccharide type 3 serum 2.2mcg; Pneumococcal polysaccharide type 4 serum 2.2mcg; Pneumococcal polysaccharide type 5 serum 2.2mcg; Serum type 6A pneumococcal polysaccharide 2.2mcg; Serum type 6B pneumococcal polysaccharide 4.4mcg; Serum type 7F pneumococcal polysaccharide 2.2mcg; Pneumococcal polysaccharide type 8 serum 2.2mcg; Serum type 9V pneumococcal polysaccharide 2.2mcg; Serum type 10A pneumococcal polysaccharide 2.2mcg; Serum type 11A pneumococcal polysaccharide 2.2mcg; Serum type 12F pneumococcal polysaccharide 2.2mcg; Pneumococcal polysaccharide type 14 serum 2.2mcg; Serum type 15B pneumococcal polysaccharide 2.2mcg; Serum type 18C pneumococcal polysaccharide 2.2mcg; Serum type 19A pneumococcal polysaccharide 2.2mcg; Serum type 19F pneumococcal polysaccharide 2.2mcg; Serum type 22F pneumococcal polysaccharide 2.2mcg; Serum type 23F pneumococcal polysaccharide 2.2mcg; Serum type 33F pneumococcal polysaccharide 2.2mcg; (20 pneumococcal-saccharide conjugates with CRM197)
    Group 1
    Each single dose of 0.5ml: Pneumococcal polysaccharide type 1 serum 2.2mcg; Pneumococcal polysaccharide type 3 serum 2.2mcg; Pneumococcal polysaccharide type 4 serum 2.2mcg; Pneumococcal polysaccharide type 5 serum 2.2mcg; Serum type 6A pneumococcal polysaccharide 2.2mcg; Serum type 6B pneumococcal polysaccharide 4.4mcg; Serum type 7F pneumococcal polysaccharide 2.2mcg; Pneumococcal polysaccharide type 8 serum 2.2mcg; Serum type 9V pneumococcal polysaccharide 2.2mcg; Serum type 10A pneumococcal polysaccharide 2.2mcg; Serum type 11A pneumococcal polysaccharide 2.2mcg; Serum type 12F pneumococcal polysaccharide 2.2mcg; Pneumococcal polysaccharide type 14 serum 2.2mcg; Serum type 15B pneumococcal polysaccharide 2.2mcg; Serum type 18C pneumococcal polysaccharide 2.2mcg; Serum type 19A pneumococcal polysaccharide 2.2mcg; Serum type 19F pneumococcal polysaccharide 2.2mcg; Serum type 22F pneumococcal polysaccharide 2.2mcg; Serum type 23F pneumococcal polysaccharide 2.2mcg; Serum type 33F pneumococcal polysaccharide 2.2mcg; (20 pneumococcal-saccharide conjugates with CRM197)
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    2.000
    5
    Flu vaccine
    A/Guangdong-Maonan/SWL1536/2019 (H1NA)pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909); A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208); B/Washington/02/2019-like strain (B/Washington/02/2019, wild type)
    Group 1
    Each 0.5 ml of vaccine contains: A/Guangdong-Maonan/SWL1536/2019 (H1NA)pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909) 15mcg heamagglutinin; A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208) 15mcg heamagglutinin; B/Washington/02/2019-like strain (B/Washington/02/2019, wild type) 15mcg heamagglutinin
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    3.000
    6
    HPV vaccine
    Each dose of 0.5ml contains 30mcg protein L1 HPV type 6; 40mcg protein L1 HPV type 11; 60mcg protein L1 HPV type 16; 40mcg protein l1 hpv type 18; 20mcg protein L1 HPV for each type 31,33,45,52 and 58
    Group 1
    0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    900
    7
    Chickenpox vaccine
    Live attenuated varicella virus (OKA strain) ≥103.3 PFU
    Group 1
    ≥ 103.3 pfu
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    300
    8
    Vaccine to prevent shingles
    Each dose of 0.5ml after reconciliation contains 50mcg antigens GE recombinant of the Varicella Zoster virus (VZV) is supplemented with AS01B
    Group 1
    Each reconstituted 0.5ml dose contains 50mcg of recombinant gE antigen of Varicella Zoster virus (VZV) adjuvanted with AS01B
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    9
    Vaccine to prevent respiratory syncytial virus
    After reconciliation, 1 dose (0.5ml) contains 120mcg of RSVPREF3 antigen that is added with AS01E. RSVPREF3: Glycoprotein F of the respiratory microscopic microorganisms (RSV) is stable in the form of consolidated currency RSVPREF3. AS01E supplementary system includes Quillaja Saponaria Molina extract, segment 21 (QS-21) 25MCG and 3-O-DESACYL-4’-Monophosphoryl Lipid A (MPL) from Salmonella Minnesota 25 mcg
    Group 1
    After reconciliation, 1 dose (0.5ml) contains 120mcg of RSVPREF3 antigen that is added with AS01E. RSVPREF3: Glycoprotein F of the respiratory microscopic microorganisms (RSV) is stable in the form of consolidated currency RSVPREF3. AS01E supplementary system includes Quillaja Saponaria Molina extract, segment 21 (QS-21) 25MCG and 3-O-DESACYL-4’-Monophosphoryl Lipid A (MPL) from Salmonella Minnesota 25 mcg
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    10
    Vaccine against RSV
    One dose (0.5ml after reconciliation) contains: antigen F stabilizes the collective fee of RSV subgroup A 0.06mg; The antigen F stabilizes the composite fee of RSV group B 0.06mg
    Group 1
    One dose (0.5ml after reconciliation) contains: antigen F stabilizes the collective fee of RSV subgroup A 0.06mg; The antigen F stabilizes the composite fee of RSV group B 0.06mg
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    11
    Vaccine against hepatitis A and B viruses
    Each dose 1.0ml contains: Hepatitis A Antigen virus (HM175 Strain) 720 Elisa Units; R-DNA Hepatitis B Virus Surface Antigen (HBsAg) 20mcg
    Group 1
    720 Elisa Units; 20mcg
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    12
    Flu vaccine
    - Pure antigen inactivates influenza A H1N1 virus - Pure antigen inactivates influenza A H3N2 virus - Pure antigen inactivates influenza B virus
    Group 2
    (Type A H1N1-15mcg; type A H3N2-15mcg; type B -15mcg)/ 0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    3.000
    13
    Refined tetanus anti -toxin serum (SAT)
    Each 1ml dose of vaccine contains 1500 IU of tetanus antitoxin globulin
    Group 4
    1500 IU
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    14
    Tetanus room vaccine
    Purified tetanus toxoid ≥ 40 IU/ 0.5ml
    Group 4
    ≥ 40 IU/0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    1.200
    15
    Vaccine against hepatitis B virus
    Pure hepatitis B virus surface ≈ 20mcg/1ml
    Group 4
    20mcg/1ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    2.000
    16
    Inactivated fragment seasonal influenza vaccine
    Purified surface antigen of influenza virus of strains: strain A/H1N1(NYMC X - 179A) A/California/ 07/2009): 15 mcg; Strain A/H3N2 (NYMC
    Group 4
    (15 mcg strain A/H3N2 + 15 mcg strain A/H1N1 + 15 mcg strain B)/0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    3.000
    17
    Refined rabies serum
    Antibodies against rabies virus 1000 IU
    Group 4
    1000 IU/Vial
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    200
    18
    Hepatitis B virus vaccine, content 20mcg/1ml
    HBsAg surface protein (purity> = 95%)
    Group 5
    20 mcg/1ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    2.000
    19
    Dengue room vaccine
    Each vaccine 0.5ml after reconciliation contains: serum type 1 virus dengue (dengue fever) (living, reducing toxicity) ≥ 3.3 log 10 pfu; Serum tube 2 virus dengue (dengue virus) (living, reducing poison) ≥ 2.7 log 10 pfu; Serum tube 3 virus dengue (dengue virus) (living, reducing poison) ≥ 4.0 log 10 pfu; Serum tube 4 Virus Dengue (Dengue Virus) (Living, reducing poison) ≥ 4.5 log 10 pfu
    Group 5
    Each vaccine 0.5ml after reconciliation contains: serum type 1 virus dengue (dengue fever) (living, reducing toxicity) ≥ 3.3 log 10 pfu; Serum tube 2 virus dengue (dengue virus) (living, reducing poison) ≥ 2.7 log 10 pfu; Serum tube 3 virus dengue (dengue virus) (living, reducing poison) ≥ 4.0 log 10 pfu; Serum tube 4 Virus Dengue (Dengue Virus) (Living, reducing poison) ≥ 4.5 log 10 pfu
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    500
    20
    Rabies vaccine
    Refined antigen from rabies virus (strain L.Pasteur 2061/Vero)
    Group 5
    ≥ 2.5IU/ 0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    1.000
    21
    Rabies vaccine
    Rabies virus (Pitman Moore strain) inactivated by beta-propiolactone was propagated in Vero cells
    Group 5
    ≥2.5 IU/0.5ml
    Inject
    Injection
    Bottle/ Vial/ Tube/ Box/ Dose/ Syringe
    1.000
    Utilities for you
    Follow quote requests
    The Track Request for Quotation function helps you quickly and promptly receive email notifications of changes to Request for Quotation "Request quotation". Our software will track the requests for quotations that you have registered for you. When there is any change, it will immediately send you an email notification.
    Receive similar quote requests via email
    To be one of the first to receive similar Requests for Quotations by email: "Request quotation" as soon as they are published, subscribe to DauThau.info's VIP 8 package.
    Sign up for package VIP 8
    Views: 4

    Select columns to display


    Greeting
    Greeting,
    You are not logged in, please log in to use our various functions for members.

    You can use your account on DauThau.info to log in to Dauthau.Net, and vice versa!

    If you are still not our member, please sign up.

    Only 5 minutes and absolutely free! Your account can be use on all over our ecosystem, including DauThau.info and DauThau.Net.

    Search for bid information
    Click for advanced search
    Latest news
    Statistical
    • 5,948 Projects are waiting for contractors
    • 44 Tender notices posted in the last 24 hours
    • 236 Contractor selection plan posted in the last 24 hours
    • 14,235 Tender notices posted in the past month
    • 52,267 Contractor selection plan posted in the last month
    You did not use the site, Click here to remain logged. Timeout: 60 second